市場調查報告書
商品編碼
1054280

日本的病患監測設備市場 (2022∼2027年):成長、趨勢、COVID-19影響、預測

Japan Patient Care Monitoring Equipment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 68 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

日本的病患監測設備的市場規模,由於慢性病患的負擔增加和家庭及遠程監控偏好的傾向高漲等要素,在預測期間內預計以4.6%的年複合成長率成長。

循環系統疾病,是增加日本的罹患率及死亡率的主要原因之一。還有慢性阻塞性肺病 (COPD) 佔日本的社會經濟負擔的很大部分。這樣的病患負擔增加在預測期間內預計增加監控系統的需求。

本報告提供日本的病患監測設備的市場調查,市場概要,市場的各種影響因素的分析,市場規模的變化、預測,設備類型、用途、終端用戶等各種區分的明細,主要企業簡介等彙整資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 市場成長的促進因素
  • 市場成長的阻礙因素
  • 波特的五力分析

第5章 市場分類

  • 各設備類型
    • 血液循環動態監測設備
    • 神經監測設備
    • 心臟監測設備
    • 多參數監護儀
    • 呼吸監測設備
    • 遠端患者監護設備
    • 其他
  • 各用途
    • 心臟病
    • 神經
    • 呼吸系統
    • 胎兒、新生兒
    • 體重管理、健身監測
    • 其他
  • 各終端用戶
    • 家庭醫療保健
    • 醫院、診所
    • 其他

第6章 競爭情形

  • 企業簡介
    • Abbott Laboratories
    • General Electric Company(GE Healthcare)
    • Boston Scientific Corporation
    • Nihon Kohden Corporation
    • Siemens Healthcare GmbH
    • Koninklijke Philips NV
    • Baxter International Inc
    • Becton, Dickinson and Company
    • Omron Corporation

第7章 市場機會、未來趨勢

目錄
Product Code: 47529

The Japan Patient Monitoring Market is expected to register a CAGR of 4.6% during the forecast period, owing to the factors such as the increasing burden of chronic disorders and growing preference for home and remote monitoring.

Cardiovascular diseases are one the leading cause of increased morbidity and mortality in Japan. According to the Ministry of Health, Labour and Welfare of Japan, in Japan, in 2018, about 162 men per 100,000 population died from heart diseases, an increase from around 135 men per 100,000 inhabitants in 2007. Heart diseases, excluding hypertensive heart diseases, were the leading cause of deaths among the male population in the country in 2018 after malignant neoplasms.

In addition, according to a research article by Ataru Igarashi et al., published in International Journal of Chronic Obstructive Pulmonary Disease 2018, Chronic obstructive pulmonary disease (COPD) represents a significant socioeconomic burden in Japan. In Japan, COPD patients report significant use of health care resources. Higher impact on work impairment and productivity loss was observed frequently in the working age population.Therefore the growing burden of such diseases is expected to increase the demand for monitoring systems in the market during the forecast period.

Key Market Trends

Weight Management & Fitness Monitoring is Expected to Show a Significant Growth Rate During the Forecast Period

In Japan, the adoption of sedentary lifestyle such as physcial inactivity, poor diet, high consumption of sugar,etc. has led to many of the chronic conditions such as diabetes, obesity, cardiovascular diseases and others. Japan has the world's fastest ageing population. According to the World Ageing 2019 report, estimates that number of population who are above 65 years of age in Japan was 35.524 million (28%) in 2019 which is projected to reach 37.278 million (30.9%) in 2030. As number of geriatric population is expected to increase in coming years who are more prone to chronic diseases such as diabetes and other diseases which ultimately rises the growth of market in near future. Hence, it has become essential to manage patients overall health and therefore, these factors are expected to increase the demand for weight management & fitness monitoring.

Competitive Landscape

The Japan Patient Monitoring Market is fragmented. The market players in the Japan Patient Monitoring Market are Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., General Electric Company (GE Healthcare), Nihon Kohden Corporation, Siemens Healthcare GmBH and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Chronic Diseases due to Lifestyle Changes
    • 4.2.2 Growing Preference for Home and Remote Monitoring
  • 4.3 Market Restraints
    • 4.3.1 Resistance from Healthcare Industry Professionals Toward the Adoption of Patient Monitoring Systems
    • 4.3.2 High Cost of Technology
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type of Device
    • 5.1.1 Hemodynamic Monitoring Devices
    • 5.1.2 Neuromonitoring Devices
    • 5.1.3 Cardiac Monitoring Devices
    • 5.1.4 Multi-parameter Monitors
    • 5.1.5 Respiratory Monitoring Devices
    • 5.1.6 Remote Patient Monitoring Devices
    • 5.1.7 Other Types of Devices
  • 5.2 By Application
    • 5.2.1 Cardiology
    • 5.2.2 Neurology
    • 5.2.3 Respiratory
    • 5.2.4 Fetal and Neonatal
    • 5.2.5 Weight Management and Fitness Monitoring
    • 5.2.6 Other Applications
  • 5.3 By End Users
    • 5.3.1 Home Healthcare
    • 5.3.2 Hospitals and Clinics
    • 5.3.3 Other End Users

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 General Electric Company (GE Healthcare)
    • 6.1.3 Boston Scientific Corporation
    • 6.1.4 Nihon Kohden Corporation
    • 6.1.5 Siemens Healthcare GmbH
    • 6.1.6 Koninklijke Philips N.V.
    • 6.1.7 Baxter International Inc
    • 6.1.8 Becton, Dickinson and Company
    • 6.1.9 Omron Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS